HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 15 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
TENT4B
terminal nucleotidyltransferase 4B
Chromosome 16 · 16q12.1
NCBI Gene: 64282Ensembl: ENSG00000121274.14HGNC: HGNC:30758UniProt: A0A7N4YH79
58PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Highly Constrained
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
RNA bindingprotein bindingtelomerase RNA bindingpositive regulation of 3'-UTR-mediated mRNA stabilizationatrial fibrillationAbnormality of the vertebral columnAlzheimer diseasehypertrophic cardiomyopathy
✦AI Summary

TENT4B (terminal nucleotidyltransferase 4B) is a non-canonical RNA polymerase that catalyzes the addition of ATP and GTP to mRNA 3' poly(A) tails, generating mixed adenosine-guanosine tails that protect transcripts from rapid deadenylation 1. This mixed tailing mechanism shields mRNA from the CCR4-NOT deadenylase complex, stabilizing mRNAs and maintaining their cellular abundance 1. TENT4B functions as a catalytic subunit in TRAMP-like complexes involved in post-transcriptional quality control, catalyzing short oligo(A) tail addition to nuclear RNAs targeted for exosome-mediated degradation. It regulates cytoplasmic polyadenylation of metabolic mRNAs, including the glucose transporter SLC2A1/GLUT1, and mediates adenylation of miR-21 and H/ACA box snoRNAs, promoting their maturation or degradation depending on downstream processing 23. Recent evidence reveals TENT4B synthesizes unusually long "starRNA" molecules consisting of rRNA fragments with mixed tails, driving amyloidogenic phase transitions in nucleoli 4. Clinically, TENT4B inhibition selectively degrades hepatitis B virus RNA, suggesting therapeutic potential as an antiviral agent 5. Additionally, dysregulation of TENT4B-mediated miRNA adenylation contributes to hematopoietic failure in poikiloderma with neutropenia, with TENT4B inhibition rescuing defective hematopoiesis 6. TENT4B also stabilizes synthetic telomerase RNA therapeutics for extending replicative lifespan in stem cells 7.

Sources cited
1
TENT4B generates mixed poly(A) tails with guanosine residues that impede deadenylase CCR4-NOT complex and shield mRNA from rapid deadenylation
PMID: 30026317
2
TENT4B synthesizes starRNA (long untemplated RNA molecules with mixed tails) that drives amyloidogenic phase transition in nucleoli
PMID: 38805292
3
TENT4B (PAPD5) inhibition causes selective degradation of hepatitis B virus RNA
PMID: 33242518
4
TENT4B-mediated miRNA 3'-end adenylation dysregulation contributes to hematopoietic failure in poikiloderma with neutropenia; PAPD5/7 inhibition rescues hematopoiesis
PMID: 36862787
5
TENT4B catalyzes 2'-O-methyladenosine tailing to stabilize synthetic telomerase RNA, extending telomere length and replicative lifespan in stem cells
PMID: 40579489
6
TENT4B mediates 3' adenylation of miR-21 followed by trimming for degradation
PMID: 25049417
7
TENT4B mediates 3' adenylation of H/ACA box snoRNAs, enhancing stability and maturation
PMID: 22442037
Disease Associationsⓘ20
atrial fibrillationOpen Targets
0.38Weak
Abnormality of the vertebral columnOpen Targets
0.27Weak
Alzheimer diseaseOpen Targets
0.25Weak
hypertrophic cardiomyopathyOpen Targets
0.25Weak
cervical carcinomaOpen Targets
0.21Weak
adolescent idiopathic scoliosisOpen Targets
0.20Weak
liver diseaseOpen Targets
0.18Weak
hypothyroidismOpen Targets
0.16Weak
uterine fibroidOpen Targets
0.11Weak
testicular carcinomaOpen Targets
0.10Weak
Testicular Germ Cell TumorOpen Targets
0.10Weak
dyskeratosis congenitaOpen Targets
0.01Suggestive
Huntington diseaseOpen Targets
0.01Suggestive
hepatitis B virus infectionOpen Targets
0.01Suggestive
cancerOpen Targets
0.01Suggestive
infectionOpen Targets
0.01Suggestive
paraneoplastic neurologic syndromeOpen Targets
0.00Suggestive
systemic lupus erythematosusOpen Targets
0.00Suggestive
breast cancerOpen Targets
0.00Suggestive
uterine corpus endometrial carcinomaOpen Targets
0.00Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes

No related genes found for this gene.

Tissue Expression

No tissue expression data available for this gene.

Gene Interaction Network

No interaction data available for this gene.

PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted · UniProt Q8NDF8
View on AlphaFold ↗
Constraintⓘ
LOEUFⓘ
0.22Highly Constrained
pLIⓘ
1.00Intolerant
Observed/Expected LoF0.12 [0.07–0.22]
RankingsWhere TENT4B stands among ~20K protein-coding genes
  • #7,923of 20,598
    Most Researched58
  • #583of 17,882
    Most Constrained (LOEUF)0.22 · top 5%
Genes detectedTENT4B
Sources retrieved10 papers
Response time—
📄 Sources
10▼
1
Mixed tailing by TENT4A and TENT4B shields mRNA from rapid deadenylation.
PMID: 30026317
Science · 2018
1.00
2
RNA tailing machinery drives amyloidogenic phase transition.
PMID: 38805292
Proc Natl Acad Sci U S A · 2024
0.90
3
RNA 3'end tailing safeguards cells against products of pervasive transcription termination.
PMID: 39617768
Nat Commun · 2024
0.80
4
Extension of replicative lifespan by synthetic engineered telomerase RNA in patient induced pluripotent stem cells.
PMID: 40579489
Nat Biomed Eng · 2025
0.70
5
Host RNA quality control as a hepatitis B antiviral target.
PMID: 33242518
Antiviral Res · 2021
0.60